HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Mori Selected Research

inhibin beta A subunit

9/2008Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
1/2008Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
9/2004N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.
1/2003Clinical significance of the expression of activin A in esophageal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Mori Research Topics

Disease

541Neoplasms (Cancer)
11/2022 - 01/2002
150Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2002
141Neoplasm Metastasis (Metastasis)
10/2022 - 07/2002
138Stomach Neoplasms (Stomach Cancer)
08/2022 - 11/2002
91Hepatocellular Carcinoma (Hepatoma)
07/2022 - 07/2002
83Esophageal Neoplasms (Esophageal Cancer)
12/2021 - 09/2004
58Esophageal Squamous Cell Carcinoma
01/2022 - 12/2002
48Adenocarcinoma
10/2022 - 09/2002
47Lymphatic Metastasis
08/2022 - 01/2002
45Colonic Neoplasms (Colon Cancer)
10/2022 - 06/2003
41Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 10/2005
38Carcinoma (Carcinomatosis)
01/2022 - 01/2002
29Rectal Neoplasms (Rectal Cancer)
07/2022 - 01/2002
26Inflammation (Inflammations)
10/2021 - 03/2006
25Carcinogenesis
09/2020 - 02/2002
22Thrombosis (Thrombus)
01/2022 - 05/2009
22Breast Neoplasms (Breast Cancer)
01/2022 - 09/2002
18Hypoxia (Hypoxemia)
01/2022 - 11/2007
18Cholangiocarcinoma
01/2022 - 02/2002
18Body Weight (Weight, Body)
05/2021 - 09/2008
17Hemorrhage
11/2022 - 03/2011
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 02/2005
15Infections
11/2022 - 09/2009
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 10/2003
12Wounds and Injuries (Trauma)
10/2020 - 10/2008
11Liver Diseases (Liver Disease)
03/2022 - 07/2003
11Weight Loss (Weight Reduction)
01/2021 - 07/2010
10Pathologic Constriction (Stenosis)
06/2022 - 11/2009
10Adenocarcinoma of Lung
02/2022 - 05/2012
10Lung Neoplasms (Lung Cancer)
06/2021 - 01/2006
10Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
04/2021 - 12/2013
10Pain (Aches)
01/2021 - 09/2006
10Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020 - 02/2008
9Liver Neoplasms (Liver Cancer)
10/2021 - 01/2005
9Vomiting
01/2021 - 03/2012
8Liver Cirrhosis (Hepatic Cirrhosis)
05/2022 - 01/2007
8Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2022 - 05/2013
8Disease Progression
01/2022 - 05/2008

Drug/Important Bio-Agent (IBA)

80Messenger RNA (mRNA)IBA
01/2022 - 01/2002
74Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2002
56Biomarkers (Surrogate Marker)IBA
10/2022 - 08/2002
49MicroRNAs (MicroRNA)IBA
01/2022 - 04/2008
44Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 11/2008
37Indicators and Reagents (Reagents)IBA
01/2022 - 10/2005
37Biological ProductsIBA
06/2021 - 07/2002
31EnzymesIBA
01/2021 - 01/2002
30Cisplatin (Platino)FDA LinkGeneric
12/2021 - 07/2009
29Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 05/2014
26GemcitabineFDA Link
05/2022 - 11/2009
23RNA (Ribonucleic Acid)IBA
08/2021 - 01/2002
22InterferonsIBA
12/2019 - 02/2004
21AntigensIBA
01/2022 - 02/2004
21DNA (Deoxyribonucleic Acid)IBA
06/2021 - 02/2005
20Tumor Biomarkers (Tumor Markers)IBA
10/2021 - 01/2008
19Transcription Factors (Transcription Factor)IBA
08/2022 - 01/2011
19Pharmaceutical PreparationsIBA
03/2022 - 12/2009
17Docetaxel (Taxotere)FDA Link
12/2021 - 10/2009
17Complementary DNA (cDNA)IBA
06/2012 - 01/2002
16GhrelinIBA
05/2016 - 04/2010
15C-Reactive ProteinIBA
10/2021 - 11/2011
14Bevacizumab (Avastin)FDA Link
04/2022 - 01/2013
13Capecitabine (Xeloda)FDA Link
10/2022 - 05/2014
13LigandsIBA
08/2021 - 05/2002
13ErbB Receptors (EGF Receptor)IBA
01/2021 - 12/2004
12Serum AlbuminIBA
04/2022 - 06/2012
12Irinotecan (Camptosar)FDA LinkGeneric
03/2021 - 11/2010
11Cadherins (E-Cadherin)IBA
08/2022 - 01/2002
11Immune Checkpoint InhibitorsIBA
01/2022 - 09/2018
11Imatinib Mesylate (Gleevec)FDA Link
04/2020 - 01/2004
11Small Interfering RNA (siRNA)IBA
12/2018 - 10/2005
11RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2014 - 03/2007
10Leucovorin (Folinic Acid)FDA Link
10/2022 - 09/2010
10Peptides (Polypeptides)IBA
10/2022 - 02/2004
10CytokinesIBA
12/2020 - 09/2012
9VimentinIBA
08/2022 - 09/2009
9AntibodiesIBA
06/2021 - 03/2007
9SteroidsIBA
12/2019 - 09/2006
8XELOXIBA
04/2022 - 05/2014
8Calcibiotic Root Canal SealerIBA
01/2022 - 01/2010
8B7-H1 AntigenIBA
01/2022 - 07/2017

Therapy/Procedure

186Therapeutics
11/2022 - 01/2002
159Drug Therapy (Chemotherapy)
06/2022 - 01/2002
62Gastrectomy
01/2021 - 11/2009
52Neoadjuvant Therapy
01/2022 - 07/2009
45Hepatectomy
01/2022 - 11/2009
38Radiotherapy
11/2022 - 01/2002
38Esophagectomy
01/2022 - 12/2006
34Liver Transplantation
12/2021 - 11/2008
32Chemoradiotherapy
07/2022 - 08/2009
28Lymph Node Excision (Lymph Node Dissection)
04/2022 - 12/2006
27Adjuvant Chemotherapy
01/2022 - 10/2003
21Immunotherapy
05/2022 - 06/2002
20Lasers (Laser)
01/2018 - 01/2002
18Colectomy
04/2021 - 04/2014
17Operative Surgical Procedures
02/2022 - 01/2007
16Pancreatectomy
01/2020 - 01/2011
12Pancreaticoduodenectomy
01/2021 - 11/2009
12Transplantation
03/2019 - 08/2006
10Aftercare (After-Treatment)
04/2022 - 09/2002
9Laparotomy
10/2019 - 04/2003